Moneycontrol

Moneycontrol PRO

HomeNewsPaul capital

Paul Capital

Jump to

May not see 35% growth in H1 sustaining in H2: Glenmark

Glenn Saldanha, MD & CEO, Glenmark said the pharma major is growth at the rate of 30% in the Indian market and is confident of maintaining margins ahead.
Profit down 35%, but topline at record Rs 1055 cr: Glenmark

Glenn Saldanha, managing director and chief executive officer of Glenmark joins CNBC-TV18 to talk about the company's Q2 performance and highlight the way forward.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347